RHEUMATOLOGY

Mortality in SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Mortality in SLE

Chapter 57 Mortality in SLE Sasha Bernatsky, Deborah Levy, Rosalind Ramsey-Goldman, Caroline Gordon, Anisur Rahman, Ann E. Clarke It is well known that systemic lupus erythematosus (SLE) can be severe…

read more

Animal Models of SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Animal Models of SLE

Chapter 17 Animal Models of SLE Bevra Hannahs Hahn, Dwight Kono Animal models of SLE have provided an invaluable resource for defining disease pathophysiology, genetics, and therapeutic approaches. Furthermore, in…

read more

Antimalarial Medications

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Antimalarial Medications

Chapter 49 Antimalarial Medications J. Antonio Aviña-Zubieta, John M. Esdaile Introduction Paine first used quinine for the treatment of discoid lupus erythematosus.1 It was not, however, until 1951, when Page…

read more

The Pathogenesis of SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on The Pathogenesis of SLE

Chapter 3 The Pathogenesis of SLE Bevra H. Hahn The purpose of this brief chapter is to review how SLE evolves and is sustained. Ideas reflect the author’s opinions, which…

read more

Pregnancy in Women with SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Pregnancy in Women with SLE

Chapter 36 Pregnancy in Women with SLE Megan E.B. Clowse Systemic lupus erythematosus (SLE) primarily affects women of childbearing age; pregnancy is therefore a dilemma frequently encountered in this patient…

read more

Pathogenetic Mechanisms in Lupus Nephritis

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Pathogenetic Mechanisms in Lupus Nephritis

Chapter 18 Pathogenetic Mechanisms in Lupus Nephritis Anne Davidson, Celine Berthier, Matthias Kretzler The kidneys maintain homeostasis of water, minerals, electrolytes, and hydrogen ions and eliminate toxic substances produced by…

read more

Critical Issues in Drug Development for SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Critical Issues in Drug Development for SLE

Chapter 54 Critical Issues in Drug Development for SLE Ronald F. van Vollenhoven Introduction The development of new drugs for the treatment of systemic lupus erythematosus (SLE) during the first…

read more

Cardiopulmonary Disease in SLE

Sep 1, 2016 by in RHEUMATOLOGY Comments Off on Cardiopulmonary Disease in SLE

Chapter 27 Cardiopulmonary Disease in SLE Guillermo Ruiz-Irastorza, Munther Khamashta Cardiopulmonary Manifestations The heart and the lungs can frequently be affected during the course of systemic lupus erythematosus (SLE), because…

read more
Get Clinical Tree app for offline access